viral kinetics
Showing 26 - 50 of 4,688
HIV Trial in Gent (treatment interruption after in depth sampling under CART)
Completed
- HIV
- treatment interruption after in depth sampling under CART
-
Gent, Oost-Vlaanderen, BelgiumUZ Gent
Sep 29, 2021
Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19
Recruiting
- Covid19
- Plasma IgG levels
-
Lahore, Punjab, Pakistan
- +1 more
Feb 12, 2022
Chronic Hepatitis B Trial in Monterey Park (NCO-48 Fumarate 4 mg, NCO-48 Fumarate 20 mg, Tenofovir Alafenamide 25 mg)
Completed
- Chronic Hepatitis B
- NCO-48 Fumarate 4 mg
- +2 more
-
Monterey Park, CaliforniaNational Institute of Clinical Research, Inc
Jan 3, 2023
White Blood Cells Engulfing Red Blood Cells Trial in Brussel (No intervention, observational study)
Recruiting
- White Blood Cells Engulfing Red Blood Cells
- No intervention, observational study
-
Brussel, BelgiumUZ Brussel
Jan 30, 2023
Chronic Hepatitis b Trial in Shanghai (peginterferon alpha based regimen, nucleos(t)ide)
Recruiting
- Chronic Hepatitis b
- peginterferon alpha based regimen
- nucleos(t)ide
-
Shanghai, ChinaHuashan Hospital
May 20, 2021
New Treatment Strategies in Eastern European Region and in
Recruiting
- HIV-1-infection
-
Cologne, Germany
- +3 more
Nov 10, 2023
HIV Trial in United States (Abacavir sulfate, Nelfinavir mesylate, Nevirapine)
Completed
- HIV Infections
- Abacavir sulfate
- +5 more
-
Gainesville, Florida
- +11 more
Oct 27, 2021
Seroprevalence of Monkeypox Infection Among People Living With
Not yet recruiting
- Monkey Pox
- HIV Infections
- Questionnaire
- (no location specified)
Jun 20, 2023
COVID-19 Trial (Blood sample collection, Saliva sample collection, Nasopharyngeal and nasal sample collection)
Not yet recruiting
- COVID-19
- Blood sample collection
- +3 more
- (no location specified)
May 12, 2023
Chronic Granulomatous Disease, CGD Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (JSP191)
Recruiting
- Chronic Granulomatous Disease
- CGD
- JSP191
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 5, 2023
Covid 19, Corona Virus Infection Trial in Mobile (Hydroxychloroquine, Placebo)
Terminated
- Covid 19
- Corona Virus Infection
- Hydroxychloroquine
- Placebo
-
Mobile, AlabamaUniversity of South Alabama
Dec 29, 2021
HIV Trial run by the National Cancer Institute (NCI) (Acute Treatment Interruption)
Recruiting
- HIV
- Acute Treatment Interruption
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 11, 2023
Persistent SARS-CoV-2 Infection in Cancer and Impaired Immune
Not yet recruiting
- Children With Cancer
- SARS-CoV-2 Infection
-
Cairo, EgyptChildren's Cancer Hospital Egypt 57357 Cairo, Egypt
Dec 26, 2021
COVID-19 Vaccines Trial in Panama, Philippines, United States (UB-612, BNT162b2 vaccine, ChAdOx1-S vaccine)
Active, not recruiting
- COVID-19 Vaccines
- UB-612
- +3 more
-
Brownsville, Texas
- +6 more
Oct 11, 2022
Thromboelastography and Conventional Coagulation Tests in
Not yet recruiting
- Thromboelastography
- +2 more
- thromboelastography
- (no location specified)
Mar 30, 2023
Analysis of HIV-1 Replication During Antiretroviral Therapy
Enrolling by invitation
- HIV
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 13, 2023
Airway Remodeling and Rhinovirus in Asthmatics
Recruiting
- Asthma
- Respiratory Disease
- HRV-39
-
Calgary, Alberta, CanadaUniversity of Calgary
Mar 7, 2023
HIV Trial in Washington (Antiretroviral Therapy Interruption(ATI))
Enrolling by invitation
- HIV
- Antiretroviral Therapy Interruption(ATI)
-
Washington, District of Columbia
- +1 more
Sep 12, 2022
Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)
Active, not recruiting
- Chronic Granulomatous Disease Transplant
- Alemtuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Sensitivity of Frequent SARS-CoV-2 Rapid Antigen Testing Regimen
Terminated
- Covid19
- CoV-SCAN rapid COVID-19 antigen test
-
New York, New YorkColumbia University Irving Medical Center
Nov 11, 2021
SARS-CoV2 Trial in Lugano (Methylene Blue, Control Test)
Active, not recruiting
- SARS-CoV2
- Methylene Blue
- Control Test
-
Lugano, Ticino, SwitzerlandFondazione Epatocentro Ticino
Apr 19, 2022
To Assess the Reduction in the Viral Load of SARS-CoV-2 in Patients Receiving Ivermectin Compared to Those Receiving Standard
Active, not recruiting
- To Assess the Reduction in the Viral Load of SARS-CoV-2 in Patients Receiving Ivermectin Compared to Those Receiving Standard Care
-
Montfermeil, FranceGHI Le Raincy Montfermeil
Sep 9, 2021
Hematologic Cancer Trial (blood collection)
Not yet recruiting
- Hematologic Cancer
- blood collection
- (no location specified)
Mar 26, 2021
Monkey Pox Trial in Paris (Blood sample collection, urine sample collection)
Not yet recruiting
- Monkey Pox
- Blood sample collection
- urine sample collection
-
Paris, FranceCentre Médical de l'Institut Pasteur
Nov 16, 2022